Activity of the human telomerase catalytic subunit (hTERT) gene promoter could be increased by the SV40 enhancer

Bioscience, Biotechnology and Biochemistry

Volumn 68, Issue 8, 2004, Pages 1634-1639

  Song, Joon Seok ^a  

^a Korea University   (South Korea)

Author keywords

Adenovirus; hTERT promoter; SV40 enhancer; Targeted cancer gene therapy

Indexed keywords

RNA; TELOMERASE; TELOMERASE RNA;

ADENOVIRUS; ARTICLE; CELL CULTURE; ENHANCER REGION; ENZYME ACTIVE SITE; FIBROBLAST; GENE THERAPY; GENETICS; HUMAN; METHODOLOGY; NEOPLASM; PHYSIOLOGY; PROMOTER REGION; REPORTER GENE; SIMIAN VIRUS 40; VIROLOGY;

ADENOVIRIDAE; CATALYTIC DOMAIN; CELLS, CULTURED; ENHANCER ELEMENTS (GENETICS); FIBROBLASTS; GENE THERAPY; GENES, REPORTER; HUMANS; NEOPLASMS; PROMOTER REGIONS (GENETICS); RNA; SIMIAN VIRUS 40; TELOMERASE;

ADENOVIRIDAE; SIMIAE; SIMIAN VIRUS 40;

EID: 4644236049     PISSN: 09168451     EISSN: None     Source Type: Journal    
DOI: 10.1271/bbb.68.1634     Document Type: Article

References (25)

1. Hiyama, K., Hiyama, E., Ishioka, S., Yamakido, M., Inai, K., Gazddar, F. G., Piatyszek, M. A., and Shay, J. W., Telomerase activity in small-cell and non-small-cell lung cancer. J. Natl. Cancer Inst., 87, 895-901 (1995).
2. Chadeneau, C., Hay, K., Hirte, H. W., Gallinger, S., and Bacchetti, S., Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res., 55, 2533-2536 (1995).
3. Sahara, H., Nakanishi, T., Kitamoto, M., Nakashio, R., Shay, J. W., Tahara, E., Kajiyama, G., and Ide, T., Telomerase activity in human liver tissue: Comparison between chronic liver disease and hepatocellular carcinoma. Cancer Res., 55, 2734-2736 (1995).
4. Counter, C. M., Guota, J., Harley, C. B., Leber, B., and Bacchetti, S., Telomerase activity in normal leukocytes and in hematologic malignancies. Blood, 85, 2315-2320 (1995).
5. Schwartz, H. S., Juliao, S. F., Sciadini, M. F., Miller, L. K., and Butler, M. G., Telomerase activity and oncogenesis in giant cell tumor of bone. Cancer, 75, 1094-1099 (1995).
6. Sommerfeld, H. J., Meeker, A. K., Piatyszek, M. A., Bova, G. S., and Coffey, D. S., Telomerase activity: A prevalent marker of malignant human prostate tissue. Cancer Res., 56, 218-222 (1996).
7. Hiyama, E., Gollahon, L., Kataoka, T., Kuroi, K., Yokoyama, T., Gazdar, A. F., Hiyama, K., Piatyszek, M. A., and Shay, J. W., Telomerase activity in human breast tumors. J. Natl. Cancer Inst., 88, 116-122 (1996).
8. Counter, C. M., Irte, H. W., Bacchtti, S., and Harley, C. B., Telomerase activity in human ovarian carcinoma. Proc. Natl. Acad. Sci. U.S.A., 91, 2900-2904 (1994).
9. Feng, J., Funk, W. D., Wang, S. S., Weinric, A. A. A., Ciu, C. P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., Le, S., West, M. D., Harley, C. B., Andrew, W. H., Greider, C. W., and Villeponteau, B., The RNA component of human telomerase. Science, 269, 1236-1241 (1995).
10. Ito, H., Kyo, S., Kanaya, T., Takakura, M., Inoue, M., and Namiki, M., Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer. Clin. Cancer Res., 4, 1603-1608 (1998).
11. Kanaya, T., Kyo, S., Takakura, M., Ito, H., Namiki, M., and Inoue, M., hTERT is a critical determinant of telomerase activity in renal carcinoma. Int. J. Cancer, 78, 539-543 (1998).
12. Takakura, M., Kyo, S., Kanaya, T., Tanaka, M., and Inoue, M., Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res., 58, 1558-1561 (1998).
13. Izumi, H. P., Louann, C., Cynthia, A., and Carl, B., Cloning and characterization of the promoter region of the human telomerase reverse transcriptase gene. Cancer Res., 59, 826-830 (1999).
14. Masahiro, T., Satoru, K., Taro, K., Hisao, H., Jun, T., Masuo, Y., and Masaki, I., Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer 7cells. Cancer Res., 59, 551-557 (1999).
15. Majumdar, A. S., Hughes, D. E., Lichtsteiner, S. P., Wang, Z., Lebkowski, J. S., and Vasserot, A. P., The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters. Gene Ther., 8, 568-578 (2001).
16. Song, J. S., Kim, H. P., Lee, K. W., Kim, M. H., Kim, K. T., Kim, H. S., and Kim, Y. T., Adenovirus-mediated suicide gene therapy using the human telomerase catalytic subunit (hTERT) gene promoter induced apoptosis of ovarian cancer cell line. Biosci. Biotechnol. Biochem., 67, 2344-2350 (2003).
17. Becker, T. C., Noel, R. J., Coats, W. S., Gomez-Foix, A. M., Alam, T., Gerard, R. D., and Newgard, C. B., Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol., 43, 161-189 (1994).
18. Graham, F. L., and Van Der Eb, A. J., A new technique for the assay of infectivity of human adenovirus 5 DNA. Viology, 52, 456-467 (1973).
19. Komata, T., Kanzawa, T., Kondo, Y., and Kondo, S., Telomerase as a therapeutic target for malignant gliomas. Oncogene, 21, 656-663 (2002).
20. Song, J. S., Kim, S. B., Lee, K. W., Jung, H. H., Kim, M. H., Kim, K. T., Brown, R., and Kim, Y. T., Adenovirus-mediated antisense expression of telomerase template RNA induces apoptosis in lung cancer cells. J. Microbiol. Biotechnol., 12, 89-95 (2002).
21. Song, J. S., Kim, D. S., Lee, K. W., Kim, M. H., Kim, K. T., and Kim, Y. T., Adenovirus-mediated antisense telomerase with cisplatin increased susceptibility to cisplatin resistant ovarian cancer cell line. J. Microbiol. Biotechnol., 12, 711-715 (2002).
22. Wu, K. J., Carla, G., Mario, A., Natalie, S., Axel, P., Joachim, L., and Riccardo, D. F., Direct activation of TERT transcription by c-Myc. Nature Genetics, 21, 220-224 (1999).
23. Kohtaro, F., and Morinobu, T., Telomerase activity in human leukemic cell lines is inhibited by antisense pentadecadeoxynucleotides targeted against c-Myc mRNA. Biochem. Biophys. Res. Commun., 248, 368-371 (1997).
24. Reid, R., Mar, E. C., Huang, E. S., and Topal, M. D., Insertion and extension of acyclic, dideoxy, and ara nucleotides by herpesviridae, human alpha and human beta polymerases. A unique inhibition mechanism for 9-(1,3-dihydroxy-2-propoxymethyl)guanine triphosphate. J. Biol. Chem., 263, 3898-3904 (1988).
25. Beltinger, C., Fulda, S., Kammertoens, T., Meyer, E., Uckert, W., and Debatin, K. M., Herpes simplex virus thymidine kinaseyganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases. Proc. Natl. Acad. Sci. U.S.A., 96, 8699-8704 (1999).